| |
Registration |
All |
1.
Mechanisms of Neurodegeneration & Neuroprotection
Chair : Prof Ludolph |
| 09:50 |
Introduction
to The Global College of Neuroprotection and Neuroregeneration
Annual Conference 2004. |
Mr Pendleton
(UK) |
10:00 |
Viral Vectors |
Dr Deglon (Sz) |
| 10:30 |
Coffee & Posters |
10:50 |
Gene Transfer of Neurotrophic
& Antiapoptotic Factors for CNS Neuroprotection & Regeneration.
|
Prof Isenmann (D) |
11:20 |
Microglia in Neurodegeneration |
Dr Wilms
&
Dr Lucius (D)
|
| 11:50 |
Discussion |
|
2.
Mechanisms of Neurodegeneration & Neuroprotection
Chair : Prof Ludolph |
17:00 |
New Neurones & Neuroprotection
in Epilepsy & Psychiatry |
Prof Trimble (UK) |
17:40 |
Antiepileptic Drugs
as Neuroprotective Agents |
Dr Sills (UK) |
18:20 |
The Disturbance of the
Oxidants - Antioxidants Balance in Epileptic Children
|
Prof Sobaniec (Pl)
|
| 19:00 |
Coffee & Posters |
19:30 |
The Beneficial Effects
of Antioxidants such as Vitamin E in Antiepileptic Therapy |
Dr Artemowicz (Pl) |
20:10 |
Systematic Review –
Meta Analysis of Neuroprotection |
Dr McCleod (UK) |
| |
Discussion |
|
|
9th February, 2004
Chronic Neurodegenerative states
1. Movement Disorders
Chair : Prof Schapira |
| 08:00 |
Neuroprotection in Orphan
Diseases |
Prof Ludolph (D) |
| 08:40 |
Oxidative Stress-Induced
Mitochondrial Defects in Parkinson’s Disease |
Prof Adam-Vizi (H) |
| 09:10 |
From Lab to Clinic –
Trial Design Issues, Regulatory Issues and Cross Disease Fertilization
|
Prof Schapira (UK) |
| 09:40 |
Coffee & Posters |
| 10:10 |
Neuroprotective approaches
to Parkinson’s Disease
|
Prof Jenner (UK) |
| 10:40 |
Can We Modify Parkinson’s
Disease Progression. What can we Learn from Imaging Studies? |
Prof Marek (USA) |
| 11:10 |
Clinical Endpoints in
Neuroprotection Trials for Parkinson’s Disease
|
Prof Rascol (F) |
| 11:50 |
Clinical Trials Issues
in Neuroprotection
|
Prof Sir Michael Rawlins(
UK) |
| 12:20 |
Discussion |
|
2. Alzheimer’s
Disease and Dementias
Chair : Dr Relkin |
| 17:00 |
Welcome and Introduction |
Dr Relkin (USA) |
| 17:05 |
Targeting Cell Death
in Dementia
|
Dr Francis (UK) |
| 17:30 |
Donepezil Protects Neuronal
Cells Against Hypoxic & Excitotoxic Damage |
Dr Akaike (J) |
| 18:00 |
Evidence for a Neuroprotective
Action of Cholinesterase Inhibitors in Alzheimer’s Disease
|
Dr Nordberg (Sw) |
| 18:25 |
Clinical Evidence for
a Neuroprotective Effect of Donepezil
|
Dr Krishnan (USA) |
| 18:50 |
Panel Discussion
|
Dr Relkin (USA) |
| 19:00 |
Coffee & Posters |
| Chair
: Prof Szabadi |
19:15 |
Alzheimer’s Early
Indentification |
Prof Szabadi (UK) |
19:45 |
Trials to Delay the
Progression of Alzheimer’s Disease – What Have We
Learned So Far? |
Prof Rossor (UK) |
20:15 |
Early Diagnosis &
Therapy of Alzheimer’s Disease – The Role of fMRI
|
Prof Riepe (D) |
20:45 |
Discussion |
|
|
10th February, 2004
1. Acute Neuropathies and General
Neuroregenerative Approaches
Chair : Prof Sharma |
| 08:00 |
Traumatic Spinal Cord
Injuries |
Prof Sharma (Sw) |
| 08:30 |
1.Recovery of Motor
Function and Modulation of Spasticity after Spinal Grafting
of Human hNT Neurons or Neuronal Precursors in Animals with
Ischemic Paraplegia |
Prof Marsala (USA) |
| 09:00 |
2. Blood-Spinal Cord
Barrier Permentation of Neurotrophic Cytokines after Injury
|
Dr Pan (USA) |
| 09:30 |
3. Volume Transmission
of Cerebrospinal Fluid: A Role for Promoting Brain Repair after
Injury to the CNS |
Prof Johanson(USA) |
| 10:00 |
4. Melanocortins &
Neuroprotection in Injury |
Dr Skottner (Sw) |
| 10:30 |
Coffee & Posters |
| 11:00 |
Stem Cell Grafts |
Prof Schwarz (D) |
| 11:30 |
Viral Vectors as Tools
to Generate Animal Models of Diseases
|
Dr Kirik (Sw) |
| 12:00 |
Lidocaine-Magnesium
Combination for Severe Head Injury |
Dr Bonicalzi &
Dr Canavero (I)
|
| 2.
MAP-Kinase Signal Molecules as Therapeutic Targets for Neurodegenerative
Diseases
Chair : Prof Herdegen |
13:00 |
1. The role of c-Jun
N-terminal kinases in Neurodegeneration |
Prof Herdegen (D) |
13:30 |
2. Understanding JNK
Action in Neuronal Physiology and Disease |
Dr Coffey (Fin) |
14:30 |
3. Use of Cell-Permeable
Peptides to Prevent Neuronal Degeneration. |
Dr Borsello (I)
|
| 15:00 |
4. The Control of Neuronal
Apoptosis by Stress Activated Protein Kinase Signaling |
Dr Courtney (Fin) |
